Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center
|
January 29, 2011
Microarray-based gene expression studies in ovarian cancer
Hye Sook Chon, Johnathan M Lancaster
Best Practice & Research. Clinical Obstetrics & Gynaecology
|
November 5, 2002
Molecular aspects of ovarian cancer
Robert M Wenham, Johnathan M Lancaster, Andrew Berchuck
Journal of Comparative Effectiveness Research
|
November 20, 2019
Letter to the Editor
Malek B Hannouf, Dale Muzzey, Ralf Kronenwett, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 24, 2015
Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center
Reem Abdallah, Yin Xiong, Johnathan M Lancaster, et al.
Journal of Comparative Effectiveness Research
|
January 25, 2021
Economic impact of multigene panel testing for hereditary breast and ovarian cancer
Stacey Dacosta Byfield, Helen Wei, Mary DuCharme, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 2007
The accuracy of frozen pathology at time of hysterectomy in patients with complex atypical hyperplasia on preoperative biopsy
Megan D Indermaur, Brenda Shoup, Steve Tebes, et al.
Integrative Cancer Therapies
|
July 23, 2016
Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center
Patricia L Judson, Reem Abdallah, Yin Xiong, et al.
Gynecologic Oncology
|
September 21, 2014
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions
Johnathan M Lancaster, C Bethan Powell, Lee-May Chen, et al.
Gynecologic Oncology
|
December 26, 2001
A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
Michael E Carney, Johnathan M Lancaster, Clyde Ford, et al.
Cancer Research
|
May 23, 2014
Analysis of chemotherapeutic response in ovarian cancers using publicly available high-throughput data
Jesus Gonzalez Bosquet, Douglas C Marchion, HyeSook Chon, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Cancer Control : Journal of the Moffitt Cancer Center
|
January 29, 2011
Microarray-based gene expression studies in ovarian cancer
Hye Sook Chon, Johnathan M Lancaster
Best Practice & Research. Clinical Obstetrics & Gynaecology
|
November 5, 2002
Molecular aspects of ovarian cancer
Robert M Wenham, Johnathan M Lancaster, Andrew Berchuck
Journal of Comparative Effectiveness Research
|
November 20, 2019
Letter to the Editor
Malek B Hannouf, Dale Muzzey, Ralf Kronenwett, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 24, 2015
Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center
Reem Abdallah, Yin Xiong, Johnathan M Lancaster, et al.
Journal of Comparative Effectiveness Research
|
January 25, 2021
Economic impact of multigene panel testing for hereditary breast and ovarian cancer
Stacey Dacosta Byfield, Helen Wei, Mary DuCharme, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 2007
The accuracy of frozen pathology at time of hysterectomy in patients with complex atypical hyperplasia on preoperative biopsy
Megan D Indermaur, Brenda Shoup, Steve Tebes, et al.
Integrative Cancer Therapies
|
July 23, 2016
Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center
Patricia L Judson, Reem Abdallah, Yin Xiong, et al.
Gynecologic Oncology
|
September 21, 2014
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions
Johnathan M Lancaster, C Bethan Powell, Lee-May Chen, et al.
Gynecologic Oncology
|
December 26, 2001
A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
Michael E Carney, Johnathan M Lancaster, Clyde Ford, et al.
Cancer Research
|
May 23, 2014
Analysis of chemotherapeutic response in ovarian cancers using publicly available high-throughput data
Jesus Gonzalez Bosquet, Douglas C Marchion, HyeSook Chon, et al.
Page
of 8